Medication info

Baiduol Tablet 10/10mg

Prescription medicationTabletOralExpired
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›10mg / 1 tablet
Manufacturer / importer
Seoul Pharmaceutical Co., Ltd.
Appearance
White to pale yellow, double convex rectangular tablet
Packaging
30 tablets (10 tablets/PTPX3)
Approval status
Expired

MFDS item code 201902086 · Approved 2019.04.05

This product's status changed to Expired on 2024.04.05. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. The dose of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Administer this drug once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range of this drug is 10/10mg~10/40mg per day. The generally recommended initial dose is 10/20mg per day. For patients who require less reduction in LDL cholesterol, treatment may be started at 10/10mg per day. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and then adjust the dose. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have taken 10/80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg per day, administered once daily in the evening. This drug is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is required for patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see 4. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is required for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this drug once daily in the evening. Use caution and monitor carefully when administering higher doses of this drug to these patients (see 4. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is required for elderly patients. Concomitant administration with other drugs (See 5. Interactions under Precautions for Use.) Administer this drug at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.

Ingredients

Manufacturer
Seoul Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
  • diabetes
  • hypothyroidism
  • obstructive liver disease
  • chronic renal failure
View approved original text

This medication helps to reduce elevated total cholesterol, LDL-cholesterol, ApoB proteins, and triglyceride levels in patients with primary hypercholesterolemia, especially heterozygous familial and non-familial hypercholesterolemia, as well as mixed dyslipidemia, and to increase HDL-cholesterol levels. Additionally, in patients with homozygous familial hypercholesterolemia (HoFH), it is used as an adjunct to other lipid-lowering therapies or as a substitute when other treatments are ineffective. This medication should be used in conjunction with an appropriate diet that limits saturated fats and cholesterol, contributing to a reduction in the risk of atherosclerotic vascular disease caused by hypercholesterolemia through improvement of lipid levels. It is important to identify and treat any secondary causes such as diabetes and hypothyroidism prior to treatment, and to determine the treatment strategy based on lipid test results. This medication is used safely and effectively to manage blood lipid levels and improve cardiovascular health.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. The dose of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Administer this drug once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range of this drug is 10/10mg~10/40mg per day. The generally recommended initial dose is 10/20mg per day. For patients who require less reduction in LDL cholesterol, treatment may be started at 10/10mg per day. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and then adjust the dose. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have taken 10/80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg per day, administered once daily in the evening. This drug is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is required for patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see 4. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is required for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this drug once daily in the evening. Use caution and monitor carefully when administering higher doses of this drug to these patients (see 4. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is required for elderly patients. Concomitant administration with other drugs (See 5. Interactions under Precautions for Use.) Administer this drug at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.

Precautions

This medication may have side effects that affect the muscles, so if muscle pain or weakness occurs, it must be reported to a doctor immediately. Care must be taken, especially when taking high doses or certain medications together, as there is an increased risk of myopathy or rhabdomyolysis. This medication may affect liver function, so it should not be administered if there is liver disease or elevated liver function tests, and liver function should be regularly monitored during treatment. Women who are pregnant or breastfeeding should not take this medication, and women of childbearing age should use appropriate contraception. This medication can interact with various other drugs, so if other medications are being taken, it is essential to inform a healthcare provider or pharmacist. Elderly patients or those with impaired kidney function need to take extra precautions when using this medication, and dosage adjustments or further testing may be needed. During the use of this medication, unexplained muscle pain, fatigue, dyspepsia, headache, or symptoms of infection may occur; if abnormal symptoms arise, consultation with a healthcare professional is advised. There is no specific antidote for overdose, so caution must be taken not to exceed the prescribed amount, and if unusual symptoms occur, immediate medical attention is necessary. During the use of this medication, it is important to limit the intake of certain foods such as grapefruit juice, and dietary and lifestyle management is also essential.

Side effects

  • myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
Show 95 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • weakness
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • itching
  • rash
  • muscle cramps
  • immune-mediated necrotizing myopathy
  • dysgeusia
  • external ocular movement disorder
  • facial incomplete paralysis
  • tremor
  • dizziness
  • sensory disturbances
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disorders
  • depression
  • cognitive impairment
  • interstitial lung disease
  • anaphylaxis
  • angioedema
  • lupus erythematosus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • toxic epidermal necrolysis
  • mucous membrane syndrome
  • erythema multiforme
  • pancreatitis
  • hepatitis
  • cholestatic jaundice
  • liver fat changes
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • liver failure
  • appetite loss
  • vomiting
  • alopecia
  • various skin changes
  • lichen planus-like drug rash
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ophthalmoplegia
  • anemia
  • elevated aminotransferases
  • increased ALP
  • elevated gamma-GT
  • increased bilirubin levels
  • thyroid dysfunction
  • increased HbA1c
  • increased fasting blood glucose levels
  • edema
  • thirst
  • facial swelling
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucous stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • increased serum creatine phosphokinase
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly closed container. Moreover, avoid excessively hot or cold locations, and it is recommended to store it at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White to pale yellow, double convex rectangular tablet

Package unit

30 tablets (10 tablets/PTPX3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.